Primrose Therapeutics, Inc. — Form D
Primrose Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-13. The offering totals $1.5M, of which $753K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-08-13
- Form: D
- Accession: 0001499169-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $753K
- Remaining: $750K
- Investors: 1
- Date of first sale: 2010-07-30
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-146420
Issuer
- Name: Primrose Therapeutics, Inc.
- CIK: 0001499169
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 875 THIRD AVENUE, NEW YORK, NY, 10022
- Phone: 212-632-5404
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| JEFFREY S EDELMAN | Director | NEW YORK, NY |
| Mark S Kessel | Director | New York, NY |
| ZACHARY S SHARON | Director | NEW YORK, NY |
| JEFFREY S EDELMAN | Executive Officer | NEW YORK, NY |
| Mark S Kessel | Executive Officer | New York, NY |
| ZACHARY S SHARON | Executive Officer | NEW YORK, NY |
More